Florida Attorney General James Uthmeier filed a first-in-the-nation, state-led lawsuit against OpenAI and CEO Sam Altman around June 1-2, 2026, accusing the company of prioritizing profit over safety in how it built and marketed ChatGPT. The lawsuit is a marked escalation from the wrongful-death suits individual families have already filed against OpenAI: it is the first time a state government itself has sued the company over product design and safety practices, rather than over a specific incident.
What the lawsuit alleges
According to the suit, OpenAI aggressively marketed ChatGPT to the public — including to children — while allegedly concealing serious risks, suppressing internal safety warnings, and deceiving Floridians about the dangers of the product. Uthmeier’s office alleges ChatGPT has harmed children specifically by providing information relevant to school shooters and offering guidance related to self-harm, and that the chatbot fosters addictive use patterns among young users. The suit further claims ChatGPT collects data from minors without meaningful parental oversight and is prone to dangerous errors that the company allegedly downplayed publicly.
How we got here
The case follows an earlier investigation Uthmeier’s office opened into ChatGPT after an incident involving a shooting at Florida State University. That investigation appears to have laid the evidentiary groundwork for the broader lawsuit now targeting OpenAI’s product design and corporate conduct rather than a single event. It also arrives against the backdrop of a wider wave of litigation against AI chatbot makers — including the Character.AI settlements reached earlier in 2026 — but Florida’s suit is notable because it is brought by a state government using its consumer-protection and enforcement powers, not by grieving families through private wrongful-death claims.
Why this reads as a health and child-safety story, not just a tech story
ChatGPT is not a medical or mental-health product, but it is increasingly used informally for emotional support, health questions, and crisis moments — precisely the use case at the center of Florida’s allegations about self-harm guidance and addictive engagement among minors. That mirrors the pattern seen in Character.AI litigation: general-purpose conversational AI ending up as an unregulated stand-in for mental-health support, with none of the safety testing, licensing, or oversight that would apply to an actual clinical tool. For an industry watching AI move deeper into healthcare, Florida’s suit is a reminder that consumer-facing chatbots sit in the same reputational and regulatory blast radius as clinical AI, even when they were never designed for medical use.
OpenAI’s defense and the skepticism on both sides
OpenAI has publicly defended its safety measures, pointing to the guardrails and content moderation systems it has built into ChatGPT. Critics of the lawsuit — including some in the tech industry — argue that state AGs are moving into a regulatory space better suited to federal agencies or Congress, and that a patchwork of state-by-state AI lawsuits could create inconsistent standards nationally. On the other side, child-safety advocates and some lawmakers argue that the federal vacuum on AI regulation is exactly why states are stepping in: without federal rules, someone has to test whether existing consumer-protection and product-liability law applies to generative AI.
Why a state-led suit matters more than it might look
Unlike the private wrongful-death suits already filed against OpenAI, a state attorney general’s lawsuit carries the weight of a sovereign government’s investigative and enforcement authority, and it can seek injunctive relief that reshapes how a company operates going forward — not just monetary damages after the fact. If Florida succeeds, or even extracts a significant settlement, it could set a template other states follow, much as state AG actions have historically shaped national policy in areas like tobacco, opioids, and data privacy.
What’s next
Expect other state attorneys general to watch Florida’s case closely as a possible model, particularly in states where lawmakers have already introduced AI chatbot-safety bills. For OpenAI, the suit adds legal and reputational pressure at a moment when it is simultaneously trying to expand ChatGPT’s role in consumer health and wellness use cases. The case will likely become an early test of how existing consumer-protection law applies to generative AI products that were never built, tested, or marketed as medical tools but are used that way by millions of people anyway.
